Goldman has not conducted a proper valuation no matter what they may say. What they have done ($9, $6.30, $5) in fact is a projection of short term share price. They are speculating and they want to be as close to the recent SP levels as possible. That's about it. Almost pathetic. At least it rhymes :)
- Forums
- ASX - By Stock
- interesting
DOW
downer edi limited
Add to My Watchlist
0.64%
!
$6.31

Goldman has not conducted a proper valuation no matter what they...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.31 |
Change
0.040(0.64%) |
Mkt cap ! $4.237B |
Open | High | Low | Value | Volume |
$6.36 | $6.38 | $6.29 | $7.298M | 1.154M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 9995 | $6.31 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.36 | 10529 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 9995 | 6.310 |
1 | 7760 | 6.300 |
1 | 2000 | 6.290 |
1 | 400 | 6.250 |
1 | 100 | 6.220 |
Price($) | Vol. | No. |
---|---|---|
6.360 | 10529 | 5 |
6.370 | 7760 | 1 |
6.390 | 2395 | 1 |
6.400 | 7594 | 6 |
6.450 | 7518 | 2 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
DOW (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online